InsidersTradesSigma
Track the 휴메딕스 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 휴메딕스 has published 2 public disclosures. Market capitalisation: €269.8bn. The latest transaction was filed on 27 April 2026 (Purchase). Among the most active insiders: 휴온스글로벌. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€115,434
2 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 485 of 29,063 companies
84.8
score / 100
Value93
Quality76
FCF yld13%
Earn yld19%
EV/EBITDA3.7x
ROE7.3%
Gross mgn47%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 April 2026
关于 휴메딕스
Humedics 是一家专注于医疗保健和制药领域的公司，在 XKRX 交易所上市。它致力于创新医疗产品的开发。